By Appsmiths
Report updated May 20, 2026
Rash ID: Skin Rash Identifier
For individuals seeking immediate, preliminary information about skin concerns or rashes to inform their next steps before consulting a healthcare professional.
Rash ID: Skin Rash Identifier is a struggling medical app that is available. With a 4.4/5 rating from 355 reviews, it struggles with user retention. Users particularly appreciate accurate identification of skin conditions provides medical value for some users, though subscription paywalls appearing before any functional scan results are provided remains a common concern.
What is Rash ID: Skin Rash Identifier?
Rash ID is an AI-powered skin analysis tool for iOS and Android that combines image scanning with symptom reporting to identify dermatological conditions.
Users hire the app to gain immediate, preliminary clarity on skin concerns, reducing the uncertainty of self-diagnosis before seeking professional medical advice.
Current Momentum
v4.5 · 2mo ago
Maintenance- Rebuilt scan history for offline sync.
- Redesigned camera interface for focus.
- Refreshed onboarding flow.
Active Nemesis
Fragmented niche
No dominant direct rival identified yet — see Other Rivals below.
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Combines image recognition with user-provided symptom descriptions.
Conversational assistant that asks targeted questions and explains reasoning.
Saves images and logs to monitor skin changes.
How much does it cost?
- Free tier: one initial Quick Scan
- Premium subscription: unlimited Quick Scans and MUM AI chat
The freemium model uses a single free-scan trial to demonstrate utility before gating the advanced conversational AI behind a subscription.
Who Built It?
Appsmiths
Providing AI-driven health and productivity utilities designed to help users navigate personal health concerns and daily organization with intelligent assistance.
Portfolio
4
Apps
Who is Appsmiths?
Appsmiths LLC is carving out a niche by applying domain-specific AI models to high-intent personal categories, moving beyond generic utilities into specialized guidance. Their strategy relies on proprietary frameworks—such as the MUM model for dermatology and the Core Operating Sentence for faith-based reflection—to create a moat of specialized data processing that is harder to replicate than standard task managers. The portfolio shows a distinct pivot toward AI-first 'companions,' signaling a move to capture the intersection of private health monitoring and personalized productivity.
Who is Appsmiths for?
- Individuals seeking private
- AI-assisted guidance for dermatological concerns
- Collaborative tools for personal or family organization
Portfolio momentum
Maintained a steady development pace with 3 releases across 4 apps in the last 6 months, including a major launch within the last 14 days.
What other apps does Appsmiths make?
What do users think recently?
Low confidence · Latest 65 of 74 total reviews analyzed · Based on 74 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate accurate identification of skin conditions provides medical value for some users, but report subscription paywalls appearing before any functional scan results are provided and technical failures during the scanning process prevent any usable output.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for Rash ID: Skin Rash Identifier?
How's The Medical Market?
How does it evolve in the Medical market?
Rash ID occupies a niche in the Medical category, but its grossing rank volatility across international markets (e.g., #30 in AE, #21 in IE) suggests an unstable revenue base. The high frequency of technical complaints relative to its 4.45 average rating indicates that current growth is driven by curiosity rather than long-term utility.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇦🇪 UAE | Medical | iOSGrossing | #42 | NEW |
| 🇳🇿 New Zealand | Medical | iOSGrossing | #43 | NEW |
The rivals identified
Peers
VisualDx
★3.9 (458)Logical Images
📈A long-standing clinical decision support tool that serves as the professional benchmark for dermatological image recognition.
Provides a massive, peer-reviewed clinical image library that serves as a professional diagnostic reference standard.
Targets medical professionals with evidence-based content rather than the consumer-facing, casual guidance of the target app.
New Kids on the Block
Eka: Health AI, ABHA, Records
★4.5 (307.5K)Orbi Health private limited
⚡Demonstrates high-velocity development with 8 releases in six months, signaling an aggressive expansion into AI-driven health management.
Integrates broad health record management and ABHA connectivity, positioning the app as a comprehensive health ecosystem.
Utilizes a high-frequency release cadence to rapidly iterate on AI features, outpacing the target app's update cycle.
The outtake for Rash ID: Skin Rash Identifier
Strengths to defend, gaps to attack
Core Strengths
- Dual-input analysis mechanism differentiates from static image-only scanners
- Secure, HIPAA-compliant data processing builds user trust
Critical Frictions
- Subscription paywall blocks functional utility for new users
- High frequency of scan failures erodes core value
- Inconsistent diagnostic results across repeated attempts
Growth Levers
- Implement pay-per-use model for infrequent users
- Expand library to include more chronic condition tracking
Market Threats
- VisualDx clinical standard undermines consumer-facing credibility
- Eka's high-velocity development cycle outpaces current update cadence
What are the next best moves?
Pivot monetization to pay-per-use because subscription paywalls trigger high churn → increase conversion rate
Subscription paywalls are the #1 complaint theme in user sentiment data.
Trade-off: Pause the annual subscription discount test — pay-per-use has higher immediate revenue potential.
Audit camera initiation logic because scan failures are the #2 complaint theme → restore basic utility
Technical failures during scanning prevent any usable output for the user.
Trade-off: Deprioritize the new skincare routine feature — stability is the current retention blocker.
A counter-intuitive read
The app's high grossing rank in new markets is a liability, as it reflects high acquisition spend on a product that is currently failing to deliver its core diagnostic promise.
Feature Gaps vs Competitors
- Peer-reviewed clinical image library (available in VisualDx but absent here)
- Broad health record management (available in Eka but absent here)
Key Takeaways
Rash ID provides a unique dual-input diagnostic tool, but the aggressive paywall and technical instability alienate the user base, so the team must prioritize scan reliability and a more flexible monetization model to prevent further churn.
Where Is It Heading?
Declining
The medical-AI market is consolidating around tools that provide verifiable clinical support, leaving Rash ID exposed due to its reliance on unverified consumer-facing diagnostics. Unless the team resolves the core scan failures and shifts to a more user-friendly monetization model, the app will continue to lose ground to more stable, multi-functional health platforms.
Technical scan failures in the latest release prevent usable output, which compounds the rating drag already visible on Android.
The subscription-first monetization model alienates new users, leading to high churn and negative sentiment regarding the app's transparency.